Flagstaff, AZ, United States of America

Levon M Majure

This inventor holds 3 USPTO granted patents. Top assignee: W. L. Gore & Associates, Inc.. Active years: 2020-2026.


% Patents Active = 66.7

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2020-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Levon M Majure: Innovator in Endoluminal Delivery Systems

Introduction

Levon M Majure is a notable inventor based in Flagstaff, AZ (US). He has made significant contributions to the field of medical devices, particularly in the area of endoluminal delivery systems. With a total of 3 patents to his name, Majure's work has the potential to enhance patient care and improve surgical outcomes.

Latest Patents

Majure's latest patents focus on innovative delivery systems and methods for endoluminal delivery of branched vascular endoprosthetic devices. One of his patents describes a catheter assembly designed for the delivery of an expandable implant that features at least one branch portal. This assembly utilizes a secondary sleeve to releasably constrain a middle portion of the expandable implant after the primary constraining sleeve is released. This design is crucial for ensuring the proper configuration of the implant during endoluminal delivery.

Career Highlights

Levon M Majure is currently employed at W. L. Gore & Associates, Inc., a company renowned for its advancements in medical technology. His work at this organization has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to medical innovation.

Collaborations

Some of Majure's coworkers include Larry L Gibbs and Jonathan W Thom. Their collaborative efforts contribute to the development of cutting-edge medical solutions that address complex health challenges.

Conclusion

Levon M Majure's innovative work in endoluminal delivery systems exemplifies the impact of dedicated inventors in the medical field. His patents not only reflect his expertise but also hold promise for improving patient outcomes in vascular procedures.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…